CVS HEALTH CORP (CVS.DE) Fundamental Analysis & Valuation

FRA:CVS • US1266501006

Current stock price

61.55 EUR
+0.38 (+0.62%)
Last:

This CVS.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. CVS.DE Profitability Analysis

1.1 Basic Checks

  • In the past year CVS was profitable.
  • CVS had a positive operating cash flow in the past year.
  • In the past 5 years CVS has always been profitable.
  • CVS had a positive operating cash flow in each of the past 5 years.
CVS.DE Yearly Net Income VS EBIT VS OCF VS FCFCVS.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B

1.2 Ratios

  • CVS's Return On Assets of 0.70% is on the low side compared to the rest of the industry. CVS is outperformed by 70.37% of its industry peers.
  • The Return On Equity of CVS (2.35%) is worse than 70.37% of its industry peers.
  • CVS has a Return On Invested Capital (4.90%) which is in line with its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CVS is in line with the industry average of 5.91%.
Industry RankSector Rank
ROA 0.7%
ROE 2.35%
ROIC 4.9%
ROA(3y)1.95%
ROA(5y)2.24%
ROE(3y)6.46%
ROE(5y)7.21%
ROIC(3y)5.46%
ROIC(5y)6.31%
CVS.DE Yearly ROA, ROE, ROICCVS.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

1.3 Margins

  • Looking at the Profit Margin, with a value of 0.44%, CVS is doing worse than 70.37% of the companies in the same industry.
  • In the last couple of years the Profit Margin of CVS has declined.
  • CVS has a Operating Margin of 2.58%. This is in the lower half of the industry: CVS underperforms 74.07% of its industry peers.
  • In the last couple of years the Operating Margin of CVS has declined.
  • CVS has a Gross Margin of 13.77%. This is in the lower half of the industry: CVS underperforms 62.96% of its industry peers.
  • In the last couple of years the Gross Margin of CVS has declined.
Industry RankSector Rank
OM 2.58%
PM (TTM) 0.44%
GM 13.77%
OM growth 3Y-19.74%
OM growth 5Y-12.87%
PM growth 3Y-30.97%
PM growth 5Y-30.29%
GM growth 3Y-6.6%
GM growth 5Y-5.48%
CVS.DE Yearly Profit, Operating, Gross MarginsCVS.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. CVS.DE Health Analysis

2.1 Basic Checks

  • CVS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, CVS has more shares outstanding
  • CVS has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, CVS has an improved debt to assets ratio.
CVS.DE Yearly Shares OutstandingCVS.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
CVS.DE Yearly Total Debt VS Total AssetsCVS.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B 200B 250B

2.2 Solvency

  • CVS has an Altman-Z score of 2.30. This is not the best score and indicates that CVS is in the grey zone with still only limited risk for bankruptcy at the moment.
  • CVS has a Altman-Z score of 2.30. This is in the better half of the industry: CVS outperforms 74.07% of its industry peers.
  • The Debt to FCF ratio of CVS is 8.27, which is on the high side as it means it would take CVS, 8.27 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 8.27, CVS is in the better half of the industry, outperforming 62.96% of the companies in the same industry.
  • CVS has a Debt/Equity ratio of 0.80. This is a neutral value indicating CVS is somewhat dependend on debt financing.
  • CVS's Debt to Equity ratio of 0.80 is in line compared to the rest of the industry. CVS outperforms 55.56% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 8.27
Altman-Z 2.3
ROIC/WACC0.63
WACC7.75%
CVS.DE Yearly LT Debt VS Equity VS FCFCVS.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.3 Liquidity

  • CVS has a Current Ratio of 0.84. This is a bad value and indicates that CVS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CVS has a Current ratio of 0.84. This is comparable to the rest of the industry: CVS outperforms 48.15% of its industry peers.
  • CVS has a Quick Ratio of 0.84. This is a bad value and indicates that CVS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of CVS (0.63) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.63
CVS.DE Yearly Current Assets VS Current LiabilitesCVS.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. CVS.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 24.54% over the past year.
  • Measured over the past years, CVS shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.11% on average per year.
  • Looking at the last year, CVS shows a small growth in Revenue. The Revenue has grown by 7.85% in the last year.
  • The Revenue has been growing by 8.39% on average over the past years. This is quite good.
EPS 1Y (TTM)24.54%
EPS 3Y-8.11%
EPS 5Y-2.11%
EPS Q2Q%-8.4%
Revenue 1Y (TTM)7.85%
Revenue growth 3Y7.63%
Revenue growth 5Y8.39%
Sales Q2Q%8.17%

3.2 Future

  • Based on estimates for the next years, CVS will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.88% on average per year.
  • The Revenue is expected to grow by 4.08% on average over the next years.
EPS Next Y7.45%
EPS Next 2Y10.69%
EPS Next 3Y12.48%
EPS Next 5Y10.88%
Revenue Next Year1.39%
Revenue Next 2Y2.92%
Revenue Next 3Y3.5%
Revenue Next 5Y4.08%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CVS.DE Yearly Revenue VS EstimatesCVS.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100B 200B 300B 400B 500B
CVS.DE Yearly EPS VS EstimatesCVS.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

5

4. CVS.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 10.56 indicates a reasonable valuation of CVS.
  • Compared to the rest of the industry, the Price/Earnings ratio of CVS indicates a rather cheap valuation: CVS is cheaper than 81.48% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 25.50, CVS is valued rather cheaply.
  • The Price/Forward Earnings ratio is 9.82, which indicates a very decent valuation of CVS.
  • 81.48% of the companies in the same industry are more expensive than CVS, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of CVS to the average of the S&P500 Index (22.67), we can say CVS is valued rather cheaply.
Industry RankSector Rank
PE 10.56
Fwd PE 9.82
CVS.DE Price Earnings VS Forward Price EarningsCVS.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • The rest of the industry has a similar Price/Free Cash Flow ratio as CVS.
Industry RankSector Rank
P/FCF 11.61
EV/EBITDA N/A
CVS.DE Per share dataCVS.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200 250

4.3 Compensation for Growth

  • CVS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as CVS's earnings are expected to grow with 12.48% in the coming years.
PEG (NY)1.42
PEG (5Y)N/A
EPS Next 2Y10.69%
EPS Next 3Y12.48%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. CVS.DE Dividend Analysis

5.1 Amount

  • CVS has a Yearly Dividend Yield of 3.70%.
  • CVS's Dividend Yield is rather good when compared to the industry average which is at 1.96. CVS pays more dividend than 92.59% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, CVS pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.7%

5.2 History

  • The dividend of CVS has a limited annual growth rate of 5.96%.
Dividend Growth(5Y)5.96%
Div Incr Years3
Div Non Decr Years5
CVS.DE Yearly Dividends per shareCVS.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5.3 Sustainability

  • CVS pays out 192.14% of its income as dividend. This is not a sustainable payout ratio.
  • CVS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP192.14%
EPS Next 2Y10.69%
EPS Next 3Y12.48%
CVS.DE Yearly Income VS Free CF VS DividendCVS.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B
CVS.DE Dividend Payout.CVS.DE Dividend Payout, showing the Payout Ratio.CVS.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CVS.DE Fundamentals: All Metrics, Ratios and Statistics

CVS HEALTH CORP

FRA:CVS (3/24/2026, 7:00:00 PM)

61.55

+0.38 (+0.62%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-10
Earnings (Next)04-29
Inst Owners90.76%
Inst Owner ChangeN/A
Ins Owners0.98%
Ins Owner ChangeN/A
Market Cap78.30B
Revenue(TTM)402.07B
Net Income(TTM)1.77B
Analysts79.39
Price Target81.34 (32.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.7%
Yearly Dividend2.32
Dividend Growth(5Y)5.96%
DP192.14%
Div Incr Years3
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.24%
Min EPS beat(2)8.8%
Max EPS beat(2)15.69%
EPS beat(4)4
Avg EPS beat(4)19.56%
Min EPS beat(4)8.8%
Max EPS beat(4)30.76%
EPS beat(8)6
Avg EPS beat(8)7.29%
EPS beat(12)10
Avg EPS beat(12)6.2%
EPS beat(16)14
Avg EPS beat(16)5.76%
Revenue beat(2)2
Avg Revenue beat(2)2.03%
Min Revenue beat(2)1.02%
Max Revenue beat(2)3.04%
Revenue beat(4)4
Avg Revenue beat(4)1.93%
Min Revenue beat(4)0.02%
Max Revenue beat(4)3.64%
Revenue beat(8)5
Avg Revenue beat(8)0.75%
Revenue beat(12)9
Avg Revenue beat(12)1.31%
Revenue beat(16)13
Avg Revenue beat(16)2.17%
PT rev (1m)1.44%
PT rev (3m)5.88%
EPS NQ rev (1m)-0.21%
EPS NQ rev (3m)-0.37%
EPS NY rev (1m)0.16%
EPS NY rev (3m)0.47%
Revenue NQ rev (1m)-2.01%
Revenue NQ rev (3m)-1.71%
Revenue NY rev (1m)-1.19%
Revenue NY rev (3m)-3.21%
Valuation
Industry RankSector Rank
PE 10.56
Fwd PE 9.82
P/S 0.23
P/FCF 11.61
P/OCF 8.52
P/B 1.2
P/tB N/A
EV/EBITDA N/A
EPS(TTM)5.83
EY9.47%
EPS(NY)6.27
Fwd EY10.18%
FCF(TTM)5.3
FCFY8.62%
OCF(TTM)7.23
OCFY11.74%
SpS273.11
BVpS51.09
TBVpS-24.3
PEG (NY)1.42
PEG (5Y)N/A
Graham Number81.86
Profitability
Industry RankSector Rank
ROA 0.7%
ROE 2.35%
ROCE 6.3%
ROIC 4.9%
ROICexc 5.23%
ROICexgc 18.66%
OM 2.58%
PM (TTM) 0.44%
GM 13.77%
FCFM 1.94%
ROA(3y)1.95%
ROA(5y)2.24%
ROE(3y)6.46%
ROE(5y)7.21%
ROIC(3y)5.46%
ROIC(5y)6.31%
ROICexc(3y)5.85%
ROICexc(5y)6.83%
ROICexgc(3y)22.7%
ROICexgc(5y)25.24%
ROCE(3y)7.06%
ROCE(5y)8.13%
ROICexgc growth 3Y-15.72%
ROICexgc growth 5Y-3.91%
ROICexc growth 3Y-15.74%
ROICexc growth 5Y-5.12%
OM growth 3Y-19.74%
OM growth 5Y-12.87%
PM growth 3Y-30.97%
PM growth 5Y-30.29%
GM growth 3Y-6.6%
GM growth 5Y-5.48%
F-Score6
Asset Turnover1.59
Health
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 8.27
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.7%
Interest Coverage -3.47
Cash Conversion N/A
Profit Quality 441.57%
Current Ratio 0.84
Quick Ratio 0.63
Altman-Z 2.3
F-Score6
WACC7.75%
ROIC/WACC0.63
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.77%
Cap/Sales(5y)0.8%
Profit Quality(3y)234.42%
Profit Quality(5y)242.41%
High Growth Momentum
Growth
EPS 1Y (TTM)24.54%
EPS 3Y-8.11%
EPS 5Y-2.11%
EPS Q2Q%-8.4%
EPS Next Y7.45%
EPS Next 2Y10.69%
EPS Next 3Y12.48%
EPS Next 5Y10.88%
Revenue 1Y (TTM)7.85%
Revenue growth 3Y7.63%
Revenue growth 5Y8.39%
Sales Q2Q%8.17%
Revenue Next Year1.39%
Revenue Next 2Y2.92%
Revenue Next 3Y3.5%
Revenue Next 5Y4.08%
EBIT growth 1Y6.02%
EBIT growth 3Y-13.61%
EBIT growth 5Y-5.55%
EBIT Next Year24.52%
EBIT Next 3Y15.26%
EBIT Next 5YN/A
FCF growth 1Y23.41%
FCF growth 3Y-16.58%
FCF growth 5Y-10.28%
OCF growth 1Y16.82%
OCF growth 3Y-13.04%
OCF growth 5Y-7.68%

CVS HEALTH CORP / CVS.DE Fundamental Analysis FAQ

What is the fundamental rating for CVS stock?

ChartMill assigns a fundamental rating of 4 / 10 to CVS.DE.


What is the valuation status of CVS HEALTH CORP (CVS.DE) stock?

ChartMill assigns a valuation rating of 5 / 10 to CVS HEALTH CORP (CVS.DE). This can be considered as Fairly Valued.


What is the profitability of CVS stock?

CVS HEALTH CORP (CVS.DE) has a profitability rating of 3 / 10.


Can you provide the expected EPS growth for CVS stock?

The Earnings per Share (EPS) of CVS HEALTH CORP (CVS.DE) is expected to grow by 7.45% in the next year.


Can you provide the dividend sustainability for CVS stock?

The dividend rating of CVS HEALTH CORP (CVS.DE) is 6 / 10 and the dividend payout ratio is 192.14%.